(Q80337563)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503095%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Kinetics and mechanism of the reduction of (ImH)[trans-RuCl4(dmso)(Im)] by ascorbic acid in acidic aqueous solution (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503095%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503095%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Malgorzata Brindell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503095%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Dorota Piotrowska

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503095%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Azza A Shoukry

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503095%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Rudi van Eldik

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503095%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

15 May 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503095%20AND%20SRC:MED&resulttype=core&format=json

Journal of Biological Inorganic Chemistry

30 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503095%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503095%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503095%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

809-818

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503095%20AND%20SRC:MED&resulttype=core&format=json

A kinetic study of the chemical stability of the antimetastatic ruthenium complex NAMI-A.

30 December 2019

cites work

1 reference

12 December 2020

Molecular interactions of ruthenium complexes in isolated mammalian nuclei and cytotoxicity on V79 cells in culture

1 reference

12 December 2020

Metal-based antitumour drugs in the post genomic era.

1 reference

12 December 2020

Dual Action of NAMI-A in inhibition of solid tumor metastasis: selective targeting of metastatic cells and binding to collagen.

1 reference

12 December 2020

DNA as a possible target for antitumor ruthenium(III) complexes

1 reference

12 December 2020

The hydrolysis of the anti-cancer ruthenium complex NAMI-A affects its DNA binding and antimetastatic activity: an NMR evaluation

1 reference

12 December 2020

Antiangiogenic properties of selected ruthenium(III) complexes that are nitric oxide scavengers.

1 reference

12 December 2020

Primary tumor, lung and kidney retention and antimetastasis effect of NAMI-A following different routes of administration

1 reference

12 December 2020

A Phase I and pharmacological study with imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent.

1 reference

12 December 2020

Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer

1 reference

12 December 2020

Inhibition of B16 melanoma metastases with the ruthenium complex imidazolium trans-imidazoledimethylsulfoxide-tetrachlororuthenate and down-regulation of tumor cell invasion.

1 reference

12 December 2020

Actin-dependent tumour cell adhesion after short-term exposure to the antimetastasis ruthenium complex NAMI-A.

1 reference

12 December 2020

Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells.

1 reference

12 December 2020

Pharmaceutical development of a parenteral lyophilized formulation of the antimetastatic ruthenium complex NAMI-A.

1 reference

12 December 2020

Redox behavior of tumor-inhibiting ruthenium(iii) complexes and effects of physiological reductants on their binding to GMP

1 reference

12 December 2020

Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer

1 reference

12 December 2020

Appraisal of the redox behaviour of the antimetastatic ruthenium(III) complex [ImH][RuCl(4)(DMSO)(Im)], NAMI-A.

1 reference

12 December 2020

Non-platinum chemotherapeutic metallopharmaceuticals

1 reference

12 December 2020

Pressure and temperature effects on metal-to-metal charge transfer in cyano-bridged CoIII-FeII complexes

1 reference

12 December 2020

Analysis of glutathione: implication in redox and detoxification

1 reference

12 December 2020

Intratumoral NAMI-A treatment triggers metastasis reduction, which correlates to CD44 regulation and tumor infiltrating lymphocyte recruitment

1 reference

12 December 2020

In vitro cell cycle arrest, in vivo action on solid metastasizing tumors, and host toxicity of the antimetastatic drug NAMI-A and cisplatin.

1 reference

12 December 2020

Influence of chemical stability on the activity of the antimetastasis ruthenium compound NAMI-A.

1 reference

12 December 2020

Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics

1 reference

12 December 2020

10.1007/S00775-007-0234-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503095%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference